Boumendjel A - Search Results

1

Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition.

Comsa E, Nguyen KA, Loghin F, Boumendjel A, Peuchmaur M, Andrieu T, Falson P. Comsa E, et al. Among authors: boumendjel a. Future Med Chem. 2018 Jun 1;10(11):1349-1360. doi: 10.4155/fmc-2017-0308. Epub 2018 May 31. Future Med Chem. 2018. PMID: 29848100

2

Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues.

Hadjeri M, Barbier M, Ronot X, Mariotte AM, Boumendjel A, Boutonnat J. Hadjeri M, et al. Among authors: boumendjel a. J Med Chem. 2003 May 22;46(11):2125-31. doi: 10.1021/jm021099i. J Med Chem. 2003. PMID: 12747785

3

Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).

Boumendjel A, Nicolle E, Moraux T, Gerby B, Blanc M, Ronot X, Boutonnat J. Boumendjel A, et al. J Med Chem. 2005 Nov 17;48(23):7275-81. doi: 10.1021/jm050705h. J Med Chem. 2005. PMID: 16279786

4

Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.

Okombi S, Rival D, Bonnet S, Mariotte AM, Perrier E, Boumendjel A. Okombi S, et al. Among authors: boumendjel a. J Med Chem. 2006 Jan 12;49(1):329-33. doi: 10.1021/jm050715i. J Med Chem. 2006. PMID: 16392817

5

Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2.

Boumendjel A, Macalou S, Ahmed-Belkacem A, Blanc M, Di Pietro A. Boumendjel A, et al. Bioorg Med Chem. 2007 Apr 15;15(8):2892-7. doi: 10.1016/j.bmc.2007.02.017. Epub 2007 Feb 13. Bioorg Med Chem. 2007. PMID: 17317193

6

Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.

Boumendjel A, Boccard J, Carrupt PA, Nicolle E, Blanc M, Geze A, Choisnard L, Wouessidjewe D, Matera EL, Dumontet C. Boumendjel A, et al. J Med Chem. 2008 Apr 10;51(7):2307-10. doi: 10.1021/jm0708331. Epub 2008 Feb 23. J Med Chem. 2008. PMID: 18293907

7

The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan.

Arnaud O, Boumendjel A, Gèze A, Honorat M, Matera EL, Guitton J, Stein WD, Bates SE, Falson P, Dumontet C, Di Pietro A, Payen L. Arnaud O, et al. Among authors: boumendjel a. Eur J Cancer. 2011 Mar;47(4):640-8. doi: 10.1016/j.ejca.2010.11.019. Epub 2011 Jan 7. Eur J Cancer. 2011. PMID: 21216589 Free PMC article.

8

Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1.

Genoux-Bastide E, Lorendeau D, Nicolle E, Yahiaoui S, Magnard S, Di Pietro A, Baubichon-Cortay H, Boumendjel A. Genoux-Bastide E, et al. Among authors: boumendjel a. ChemMedChem. 2011 Aug 1;6(8):1478-84. doi: 10.1002/cmdc.201100102. Epub 2011 Jun 1. ChemMedChem. 2011. PMID: 21634011

9

Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Haudecoeur R, Ahmed-Belkacem A, Yi W, Fortuné A, Brillet R, Belle C, Nicolle E, Pallier C, Pawlotsky JM, Boumendjel A. Haudecoeur R, et al. Among authors: boumendjel a. J Med Chem. 2011 Aug 11;54(15):5395-402. doi: 10.1021/jm200242p. Epub 2011 Jul 6. J Med Chem. 2011. PMID: 21699179 Free PMC article.

10

Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation.

Boumendjel A, Macalou S, Valdameri G, Pozza A, Gauthier C, Arnaud O, Nicolle E, Magnard S, Falson P, Terreux R, Carrupt PA, Payen L, Di Pietro A. Boumendjel A, et al. Curr Med Chem. 2011;18(22):3387-401. doi: 10.2174/092986711796504736. Curr Med Chem. 2011. PMID: 21728961 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters